We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

43 hedge funds and large institutions have $103M invested in Fibrocell Science Inc. in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 7

5% more capital invested

Capital invested by funds: $98.1M → $103M (+$5.31M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 4443 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
20
Reduced
7
Closed
10
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$101K
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$71K +$10.5K +180 +18%
NFA
27
Nationwide Fund Advisors
Ohio
$68K +$13K +224 +25%
AIG
28
American International Group
New York
$60.4K +$13.9K +239 +32%
CS
29
Credit Suisse
Switzerland
$48K +$45.9K +788 New
BA
30
BlackRock Advisors
Delaware
$44K +$11.7K +201 +39%
Barclays
31
Barclays
United Kingdom
$41K -$1.28M -21,942 -97%
Bank of America
32
Bank of America
North Carolina
$37K +$34.5K +593 +3,953%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$29K +$27.6K +474 New
Deutsche Bank
34
Deutsche Bank
Germany
$18K -$475K -8,166 -96%
Creative Planning
35
Creative Planning
Kansas
$8K
TRCT
36
Tower Research Capital (TRC)
New York
$7K +$582 +10 +10%
Group One Trading
37
Group One Trading
Illinois
$6K -$3.49K -60 -40%
Morgan Stanley
38
Morgan Stanley
New York
$4K +$3.67K +63 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$2K -$5.06K -87 -72%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$1.18K +$1.11K +19 New
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
-$1.09M -16,667 Closed
Cambridge Investment Research Advisors
42
Cambridge Investment Research Advisors
Iowa
-$847K -12,890 Closed
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
-$634K -9,645 Closed
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
-$438K -6,667 Closed
SP
45
Steelhead Partners
Washington
-$55K -833 Closed
VKH
46
Virtu KCG Holdings
New York
-$53K -806 Closed
ProShare Advisors
47
ProShare Advisors
Maryland
-$47K -710 Closed
RFC
48
Russell Frank Company
Washington
-$28K -433 Closed
Ameriprise
49
Ameriprise
Minnesota
-$5K -70 Closed
U
50
UBS
Switzerland
-$4K -55 Closed

FCSC Hedge Fund Activity: Q4 2013 in Review

43 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2013, worth a combined $103M — up 5.4% from $98.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FCSC and 9 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 20 added.

The largest buyer was Third Security, adding an estimated $14.2M. The largest seller was Barclays, cutting an estimated $1.28M.

  • 43 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2013, down from 44 in Q3 2013.
  • Funds reported $103M of Fibrocell Science Inc. stock for Q4 2013, up 5.4% quarter-over-quarter.
  • 9 funds opened new Fibrocell Science Inc. positions in Q4 2013 and 10 closed out, a net change of -1 holder.
  • The largest Fibrocell Science Inc. buyer in Q4 2013 was Third Security, an estimated $14.2M added.
  • The largest Fibrocell Science Inc. seller in Q4 2013 was Barclays, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2013.